Cargando...
Does Antipsychotic Polypharmacy Increase the Risk for Metabolic Syndrome?
OBJECTIVE: To determine whether the co-prescribing of two or more antipsychotics, a relatively frequent practice with little data to support its safety and efficacy, is associated with an increased prevalence of metabolic syndrome. METHODS: 364 newly admitted adults treated with second-generation an...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2006
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2718048/ https://ncbi.nlm.nih.gov/pubmed/17070017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2006.08.017 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|